Skip to main content
C.Q. Pharmaceutical Holding Co., Ltd. logo

C.Q. Pharmaceutical Holding Co., Ltd. — Investor Relations & Filings

Ticker · 000950 ISIN · CNE0000010K0 Shenzhen Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 2,883 across all filing types
Latest filing 2023-12-13 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 000950

About C.Q. Pharmaceutical Holding Co., Ltd.

https://www.cqphar.com

C.Q. Pharmaceutical Holding Co., Ltd. is a comprehensive pharmaceutical enterprise specializing in the distribution, retail, and supply chain management of healthcare products. The company operates an extensive network focused on the wholesale of pharmaceuticals and medical devices, providing integrated logistics and warehousing solutions to healthcare providers and manufacturers. Its core business activities encompass the procurement and distribution of a wide range of prescription drugs, over-the-counter medications, and specialized medical equipment. Through its retail pharmacy operations and third-party logistics services, the company facilitates the efficient delivery of medical supplies. C.Q. Pharmaceutical Holding Co., Ltd. emphasizes technological integration within its supply chain to optimize inventory management and ensure the integrity of healthcare products throughout the distribution lifecycle.

Recent filings

Filing Released Lang Actions
关于重药股份下属子公司重控四川为其参股子公司宜宾润宜提供财务资助的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement by Zhongyao Holdings Co., Ltd. regarding a financial assistance transaction where its subsidiary provides a loan to an associate company. It includes details about the loan amount, terms, financial status of the recipient, board approvals, and risk analysis. The document is relatively short (2778 characters) and focuses on a specific financing event rather than comprehensive financial statements or results. It does not contain full financial reports or earnings data but rather an update on a capital/financing activity. Therefore, it fits best under the category of Capital/Financing Update (CAP).
2023-12-13 Chinese
《商品购销监管办法》
Governance Information Classification · 95% confidence The document is a detailed internal regulatory manual titled '商品购销监管办法' (Commodity Purchase and Sales Supervision Measures) issued by 重药控股股份有限公司. It outlines principles, organizational responsibilities, procedures, and controls related to procurement and sales management within the company and its subsidiaries. There is no indication that this is a financial report, earnings release, or any form of regulatory filing to external bodies. It is a governance and internal control document focused on operational management and compliance within the company. It does not contain financial statements, audit opinions, or shareholder meeting materials. Therefore, the document best fits the category of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices.
2023-12-13 Chinese
第八届监事会第二十二次会议决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the supervisory board (监事会) of the company, detailing the meeting held, the agenda items discussed, and the voting results. It includes references to other announcements for detailed content but does not itself contain financial statements or detailed financial data. The document is short (769 characters) and serves as an official announcement of meeting resolutions rather than a full report or financial disclosure. This fits the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2023-12-13 Chinese
关于控股子公司2023年度第一期资产支持票据发行结果公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the issuance results of asset-backed notes by a controlling subsidiary of the company. It details the financing plan, issuance scale, types of notes, interest rates, and issuance dates. There is no detailed financial report or comprehensive financial statements included, but rather a summary of a financing activity and its results. This fits the category of Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities.
2023-11-30 Chinese
北京市竞天公诚律师事务所关于重药控股股份有限公司2023年第四次临时股东大会的律师见证法律意见书
Board/Management Information Classification · 95% confidence The document is a legal opinion letter from a law firm regarding the convening, procedures, and results of a specific shareholders' meeting (the 2023 fourth extraordinary general meeting) of a company. It details the legality of the meeting's call, attendance, voting procedures, and results, including election of directors and amendments to board rules. It does not contain financial statements or management discussion of financial results, nor is it a transcript or presentation. It is a formal legal opinion related to a shareholders meeting, focusing on governance and board/management changes. Therefore, it fits best under Board/Management Information (MANG), as it relates to board elections and governance changes confirmed by legal counsel.
2023-11-30 Chinese
关于董事会完成换届选举及聘任高级管理人员、证券事务代表的公告
Board/Management Information Classification · 100% confidence The document is an announcement from Chongqing Pharmaceutical Holdings Co., Ltd. regarding the completion of the board of directors' re-election and the appointment of senior management and securities affairs representatives. It details the composition of the new board, committee members, and provides biographies of the directors and senior management. There is no financial data, earnings information, or regulatory filings related to financial performance. The content focuses on changes in the company's board and senior management personnel. Therefore, this document fits the category of Board/Management Information (MANG). The document length is sufficient and the content is substantive, not merely an announcement of a report or certification.
2023-11-30 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.